Recent Posts
Archives
HaemaLogiX's Tertia Dex explains the KappaMab antibody
![Tertianl](https://www.irdepartment.com.au/site/irmblogpropertyfile/575/Tertianl.png)
HaemaLogix's Chief Manufacturing and Development Officer, Tertia Dex, explains the fascinating process to manufacture KappaMab, a highly-targeted antibody designed to treat mutliple myeloma.